II
BIO icon

IFM Investors’s Bio-Rad Laboratories Class A BIO Stock Holding History

IFM Investors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,219
Closed -$784K – 627
2025
Q1 		$784K Hold
3,219
– – 0.01% 582
2024
Q4 		$1.06M Sell
3,219
-226
-7% -$76.7K 0.01% 586
2024
Q3 		$1.15M Sell
3,445
-383
-10% -$122K 0.01% 583
2024
Q2 		$1.05M Sell
3,828
-229
-6% -$66.6K 0.01% 593
2024
Q1 		$1.4M Buy
+4,057
New +$1.33M 0.02% 570
2023
Q4 		– Sell
-4,057
Closed -$1.45M – 579
2023
Q3 		$1.45M Buy
4,057
+200
+5% +$77.2K 0.02% 564
2023
Q2 		$1.46M Buy
3,857
+80
+2% +$32.6K 0.02% 562
2023
Q1 		$1.81M Buy
3,777
+180
+5% +$84.3K 0.03% 507
2022
Q4 		$1.51M Hold
3,597
– – 0.03% 522
2022
Q3 		$1.5M Hold
3,597
– – 0.03% 514
2022
Q2 		$1.78M Buy
3,597
+239
+7% +$124K 0.03% 489
2022
Q1 		$1.89M Buy
3,358
+391
+13% +$236K 0.03% 500
2021
Q4 		$2.24M Sell
2,967
-80
-3% -$59.9K 0.04% 423
2021
Q3 		$2.27M Buy
3,047
+139
+5% +$104K 0.05% 399
2021
Q2 		$1.87M Buy
2,908
+608
+26% +$370K 0.04% 465
2021
Q1 		$1.31M Buy
2,300
+142
+7% +$84.1K 0.04% 476
2020
Q4 		$1.26M Buy
2,158
+325
+18% +$185K 0.04% 445
2020
Q3 		$945K Buy
1,833
+269
+17% +$136K 0.04% 413
2020
Q2 		$706K Sell
1,564
-57
-4% -$25.2K 0.04% 448
2020
Q1 		$566K Buy
1,621
+674
+71% +$248K 0.03% 503
2019
Q4 		$350K Buy
+947
New +$334K 0.01% 602

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $8.09B AUM 21.95% 1-Year Est. Return

IFM Investors's BIO Position: Q2 2025 in Review

IFM Investors sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 3,219 shares — an estimated $784K sold.

IFM Investors first reported a position in BIO in Q4 2019 and held it in 21 quarters. The position peaked at $2.27M in Q3 2021. 384 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

  • IFM Investors reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
  • IFM Investors sold 3,219 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $784K.
  • IFM Investors first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and held it in 21 quarters.
  • IFM Investors's Bio-Rad Laboratories Class A position peaked at $2.27M in Q3 2021.
  • 384 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on IFM Investors's 13F filing for Q2 2025, filed 11 Jul 2025.